Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Beauty Health Co (SKIN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.25
1 Year Target Price $2.25
| 0 | Strong Buy |
| 0 | Buy |
| 7 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -52.8% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 181.36M USD | Price to earnings Ratio - | 1Y Target Price 2.25 |
Price to earnings Ratio - | 1Y Target Price 2.25 | ||
Volume (30-day avg) 9 | Beta 1.22 | 52 Weeks Range 0.78 - 2.69 | Updated Date 10/19/2025 |
52 Weeks Range 0.78 - 2.69 | Updated Date 10/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.13% | Operating Margin (TTM) -3.45% |
Management Effectiveness
Return on Assets (TTM) -4.45% | Return on Equity (TTM) -26.55% |
Valuation
Trailing PE - | Forward PE 106.38 | Enterprise Value 380334174 | Price to Sales(TTM) 0.58 |
Enterprise Value 380334174 | Price to Sales(TTM) 0.58 | ||
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 18.37 | Shares Outstanding 126825397 | Shares Floating 81549999 |
Shares Outstanding 126825397 | Shares Floating 81549999 | ||
Percent Insiders 11.71 | Percent Institutions 86.04 |
Upturn AI SWOT
Beauty Health Co
Company Overview
History and Background
Beauty Health Co, formerly known as HydraFacial, went public via SPAC merger in 2021. It focuses on personalized skin health experiences through its HydraFacial delivery system.
Core Business Areas
- HydraFacial System Sales: Sells the HydraFacial delivery system machines and related products (tips, serums, etc.) to aesthetic providers, spas, and retailers.
- Consumables Sales: Generates recurring revenue through the sale of consumable products used with the HydraFacial system, such as serums and treatment tips.
Leadership and Structure
Andrew Stanleick is the President and CEO. The company has a board of directors overseeing strategy and governance.
Top Products and Market Share
Key Offerings
- HydraFacial Delivery System: The core product, a device providing multi-step skin health treatments. Market share is estimated at roughly 25% of the facial spa equipment market. Competitors include DermaSweep, SilkPeel, and other microdermabrasion systems. Recurring revenue is primarily derived from related consumables.
- HydraFacial Consumables (Serums, Tips): Proprietary consumables used with the HydraFacial system. Drives recurring revenue. Competitors include generic serums and tips compatible with other facial devices.
Market Dynamics
Industry Overview
The beauty and aesthetics market is growing, driven by increased consumer spending on skincare and personalized treatments. Key trends include non-invasive procedures and a focus on overall skin health.
Positioning
Beauty Health Co is positioned as a premium provider of skin health treatments, focusing on the HydraFacial brand and its patented technology. It has a competitive advantage through its established brand recognition and recurring revenue model.
Total Addressable Market (TAM)
The global facial aesthetics market is estimated to reach tens of billions of dollars. Beauty Health Co. aims to capture a significant portion of this TAM with its premium brand and recurring revenue streams.
Upturn SWOT Analysis
Strengths
- Strong Brand Recognition
- Recurring Revenue Model (Consumables)
- Patented Technology
- Global Distribution Network
Weaknesses
- High Dependence on HydraFacial System Sales
- Relatively High Price Point Compared to Alternatives
- Supply Chain Vulnerabilities
- Marketing Costs
Opportunities
- Expansion into New Geographies
- Development of New Products and Services
- Partnerships with Healthcare Providers
- Increase Brand Awareness via Marketing Initiatives
Threats
- Increased Competition in the Aesthetics Market
- Economic Downturn Affecting Consumer Spending
- Changes in Regulations
- Technological Disruptions
Competitors and Market Share
Key Competitors
- ALGN
- ZTS
- LULU
Competitive Landscape
Beauty Health Co's advantages include brand recognition and a recurring revenue model. Disadvantages include premium pricing and competitive landscape.
Major Acquisitions
Vogue Skin Group
- Year: 2020
- Acquisition Price (USD millions): 6.5
- Strategic Rationale: Expanded their market share in Australia and New Zealand, and broadened their distributor network.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been rapid since its initial public offering (IPO), driven by increased adoption of the HydraFacial system.
Future Projections: Analysts project continued revenue growth, driven by international expansion and product innovation. Profitability is expected to improve with scale.
Recent Initiatives: Focus on partnerships, digital marketing, and new product development to increase market share and customer engagement.
Summary
Beauty Health Co has strong brand recognition and recurring revenue but faces stiff competition and needs to improve profitability. Its growth trajectory depends on continued expansion and product innovation. It's a relatively young public company with volatility and is dependent on supply chain and must improve it's cost of goods sold. Beauty Health Co's long-term success hinges on its ability to maintain its premium brand image while effectively navigating market dynamics.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Beauty Health Co
Exchange NASDAQ | Headquaters Long Beach, CA, United States | ||
IPO Launch date 2020-11-24 | CEO & President Mr. Pedro Malha | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 769 | Website https://www.beautyhealth.com |
Full time employees 769 | Website https://www.beautyhealth.com | ||
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.